- Home
- CELC vs VRRM Comparison
CELC vs VRRM Comparison
Compare CELC & VRRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | VRRM |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CELC | VRRM |
|---|---|---|
| Price | $104.77 | $22.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $100.13 | $28.38 |
| AVG Volume (30 Days) | 863.3K | ★ 1.5M |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $942,717,000.00 |
| Revenue This Year | N/A | $11.68 |
| Revenue Next Year | N/A | $6.23 |
| P/E Ratio | ★ N/A | $70.60 |
| Revenue Growth | N/A | ★ 8.52 |
| 52 Week Low | $7.58 | $19.51 |
| 52 Week High | $112.64 | $27.20 |
Technical Indicators
Market Signals| Indicator | CELC | VRRM |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 58.94 |
| Support Level | $98.50 | $21.99 |
| Resistance Level | $103.09 | $22.80 |
| Average True Range (ATR) | 3.54 | 0.46 |
| MACD | -0.65 | 0.10 |
| Stochastic Oscillator | 78.85 | 87.50 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.